FTO and cancer: According to Lianyong Liu et al., circGPR137B, which shared a location with miR-4739 in the cytoplasm, served as a sponge for miR-4739 and upgraded the level of its target FTO, inhibiting cell proliferation and cancer metastasis in HCC patients.